Ethisterone
SIGMA/E1001 - ≥99% (HPLC)
Synonym: 17α-Ethynyltestosterone; 17β-Hydroxy-4,17α-pregnen-20-yn-3-one; 4,17α-Pregnen-17β-ol-20-yn-3-one
CAS Number: 434-03-7
Empirical Formula (Hill Notation): C21H28O2
Molecular Weight: 312.45
EC Number: 207-096-5
MDL Number: MFCD00003656
Linear Formula: C21H28O2
Product Type: Chemical
| assay | ≥99% (HPLC) |
| biological source | synthetic (organic) |
| drug control | regulated under CDSA - not available from Sigma-Aldrich Canada |
| form | powder |
| InChI | 1S/C21H28O2/c1-4-21(23)12 |
| InChI key | CHNXZKVNWQUJIB-CEGNMAFCSA |
| mp | 263-269 °C (lit.) |
| originator | Novartis |
| Quality Level | 200 ![]() |
| shipped in | ambient |
| SMILES string | C[C@]12CCC(=O)C=C1CC[C@@H |
| solubility | chloroform: methanol (1:1): 20 mg/mL, clear to slightly hazy, colorless to light yellow |
| sterility | non-sterile |
| storage temp. | room temp |
| technique(s) | cell culture | mammalian: suitable |
| Application: | Ethisterone has been used as a component in Dulbecco′s modified eagle medium (DMEM) to culture the transfected COS-7 cell for transient transfection assay and gene transfection assay. |
| Biochem/physiol Actions: | Ethisterone acts as a progestational agent. It is consumed by pregnant mothers to prevent miscarriage. |
| Features and Benefits: | This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Ethisterone is a progestogen. It is a danazol derivative. |
| Packaging: | 25, 100 g in glass bottle |
| Symbol | ![]() GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H360FD - H410 |
| Precautionary statements | P201 - P202 - P273 - P280 - P308 + P313 - P391 |
| Hazard Codes | T |
| Risk Statements | 61 |
| Safety Statements | 53-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥99% (HPLC) |
| mp | 263-269 °C (lit.) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |



